🟢 Marker Therapeutics is trading 7.8% up in pre-market

Marker Therapeutics is trading at $0.99, up 7.77% in pre-market, with no clear company-specific catalyst identified.

• The gain follows a 3.35% rise at the October 15 close; broad indexes are mixed pre-market, offering no clear market-wide explanation.
• The latest listed company release was September 22 and covered manufacturing support.
• An October 16 Zacks article named MRKR among strong-buy stocks based on improving earnings estimates, but did not link the item to the pre-market move.